Phase I dose-finding and pharmacokinetic trial of orally administered indibulin (D-24851) to patients with solid tumors
I. E. L. M. Kuppens, P. O. Witteveen, M. Schot, V. M. Schuessler, A. Daehling, J. H. Beijnen, E. E. Voest, J. H. M. SchellensVolume:
25
Language:
english
Pages:
9
DOI:
10.1007/s10637-006-9027-2
Date:
June, 2007
File:
PDF, 324 KB
english, 2007